RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus†or the "Company†), a global leader in cheminformatics, biosimulation, clinical operations solutions and medical communications that accelerate biopharma innovation, today reported financial results for its fourth quarter and fiscal 2025, ended August 31, 2025. Fourth Quarter 2025 Financial Highlights (as compared to fourth quarter 2024) Total revenue decreased 6% to $17.5 million Software rev. ...

Core Insights - Simulations Plus, Inc. announced preliminary results for fiscal year 2025 and provided guidance for fiscal year 2026 [1] Fiscal Year 2025 Preliminary Results - The company reported preliminary revenue figures for fiscal year 2025 [1] Fiscal Year 2026 Guidance - Management issued preliminary guidance and outlook for fiscal year 2026 [1]